ClinicalTrials.Veeva

Menu

Does Placenta Pathology Predict Outcome of Neonates With Hypoxic Ischemic Encephalopathy?"

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Completed

Conditions

Asphyxia Neonatorum

Treatments

Other: hypothermia therapy

Study type

Observational

Funder types

Other

Identifiers

NCT03284528
2017-00912

Details and patient eligibility

About

The histology of the placenta of newborn infants with perinatal asphyxia and hypoxic-ischaemic encephalopathy is analysed. There will be an evaluation if placenta could be a biomarker for neurodevelopmental outcome at 18-24 months of age.

Enrollment

100 patients

Sex

All

Ages

1 to 4 days old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:all newborn infants with APGAR <5 at 10minutes, pH<7.0, lactate >12mmol/L, base excess >16, resuscitation >10min after birth, gestational age >35 weeks and an encephalopathy -

Exclusion Criteria:

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems